Product ID:STYCAST 2072, PART A, BLACK
MSDS Date:09/22/1988
FSC:8040
NIIN:00N064006
Kit Part:Y
MSDS Number: BZJZL

EMERSON AND CUMING INC

77 DRAGON COURT
WOBURN, MA 01888
US

Emergency Phone: 617-828-3300

Info Phone: 617-935-4850

Preparer: DAVID HAAS

Cage: OB562

EMERSON AND CUMING, INC,

WOBURN, MA 01888-5000 US

Telephone: 617-935-4850/617-938-8630

Cage: OB562

CALCIUM CARBONATE

CAS: 1317-65-3

RTECS: EV9580000

Fraction By Weight: >50%

OSHA PEL 15 MG/M3 TDUST

ACGIH TLV: 10 MG/M3 TDUST

EPOXY RESIN

Fraction By Weight: <50%

OSHA PEL N/K

ACGIH TLV: N/K

N-BUTYL GLYCIDYL ETHER (BGE)

CAS: 2426-08-6

RTECS: TX4200000

Fraction By Weight: <5%

OSHA PEL 50 PPM

ACGIH TLV: 25 PPM

PIGMENT

Fraction By Weight: <0.5%

OSHA PEL N/K

ACGIH TLV: N/K

RELATED TO HUMAN EXPOSURES, HOWEVER, GOOD VENT &

RTECS: 9999999ZZ

HANDLING COMPOUNDS CONTAINING EITHER BGE OR PGE. GET

RTECS: 9999999ZZ

WATER & RINSE. PVNT RINSES FROM ENTERING DRAINS

RTECS: 9999999ZZ

CONTAIN SPILLED MATL & TO PVNT RUNOFF INTO DRAINS,

RTECS: 9999999ZZ

SALVAGE TANK. ABSORB RESIDUAL MATL W/SAND,

RTECS: 9999999ZZ

WASTE & ABSORB INTO CNTNRS. SCRUB AREA W/SOAPY WATER

RTECS: 9999999ZZ

LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: INHAL:VAPS MAY CAUSE RESP TRACT
IRRIT. EYES:IRRIT UPON DIRECT CNTCT. SKIN:IRRIT UPON DIRECT CNTCT.
PRLNGD EXPOS MAY RSLT IN SKIN SENSIT. INGEST:HARMFUL IF SWALLOWED.
CHRONIC: ALTHOUGH SIGNIFICA NCE IS UNKNOWN, EPOXY RESIN IN PROD
HASBEEN SHOWN TO BE MUTAGENIC IN SOME MICROBIAL TESTS, BUT HAS
(EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT
Effects of Overexposure:HLTH HAZ: FAILED TO SHOW MUTAGENICITY IN
OTHERS. CHROMOSOMAL ABERRATIONS WERE OBSERVED IN CULTURED RAT LIVER
CELLS. EXPOS TO FILLER MATL IS UNLIKELY TO OCCUR UNLESS PROD IS
APPLIED IN MANNER WHICH RSL TS IN GENERATION OF MISTS/FUMES OR
WHENMACHINING OF CURED PROD RSLTS IN GENERATION OF DUST PARTICLES.
RECENT (SUPDAT)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.

First Aid:INHAL: REMOVE TO FRESH AIR. GIVE OXYGEN IF BREATHING
DIFFICULT; GIVE ARTIFICIAL RESPIRATION IF NOT BREATHING; GET
IMMEDIATE MEDICAL ATTENTION. EYES: IMMEDIATELY FLUSH EYES WITH
WATER FOR AT LEAST 15 M INUTES; GET MEDICAL ATTENTION. SKIN: REMOVE
CONTAMINATED CLOTHING. WASH AFFECTED AREA WITH WATER. INGEST:
DILUTE WITH WATER. GET IMMEDIATE MEDICAL ATTENTION.

Flash Point Method:PMCC
Flash Point:251F,122C
Extinguishing Media:CARBON DIOXIDE, DRY CHEMICAL, FOAM, WATER FOG.
Fire Fighting Procedures:USE NIOSH/MSHA APPROVED SCBA AND FULL
PROTECTIVE EQUIPMENT .
Unusual Fire/Explosion Hazard:TOXIC VAPORS MAY BE EVOLVED UPON EXPOSURE
TO HEAT OR OPEN FLAME.

Spill Release Procedures:NOTE:CLEANUP OF LG SPILLS SHOULD BE DONE I/A/W
PROVISIONS OF OSHA 29CFR 1910.120 ("HAZ WASTE OPERATIONS & EMER
RESPONSE"). FOR SM SPILLS: WIPE UP/ABSORB W/VERMICULITE OR OTHER
ABSORB MATL. COLLECT WAS TE IN SEALED CNTNRS. SCRUB AREA
W/SOAPY(ING 7)
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:STORE IN COOL, DRY PLACE; KEEP REMOVED
FROM ANY HEAT, SPARK OR OPEN FLAME. KEEP CONTAINER CLOSED WHEN NOT
IN USE.
Other Precautions:SPEC PREC RECS ARE PROVIDED AS GEN GUIDANCE FOR MIN
EXPOS WHEN HNDLG PROD. BECAUSE USE CNDTNS VARY DEPENDING ON
CUSTOMER APPLICATN, SPECIFIC SAFE HNDLG PROCS SHOULD BE DEVELOPED
BY PERSON KNOWLEDGEABL E IN INTENDED USE CNDTNS & EQUIP.

Respiratory Protection:WEAR AN APPROPRIATE, PROPERLY FITTED, NIOSH/MSHA
APPROVED RESPIRATOR WHEN CONTAMINANT LEVELS EXCEED THE RECOMMENDED
EXPOSURE LIMITS.
Ventilation:PREVENT BREATHING OF VAPORS, MIST OR SPRAY. USE ONLY WITH
PROPER MECHANICAL EXHAUST VENTILATION.
Protective Gloves:IMPERVIOUS GLOVES .
Eye Protection:ANSI APPRVD CHEM WORKERS GOGGLES .
Other Protective Equipment:ANSI APPRVD EYE WASH & DELUGE SHOWER . PVNT
CNTCT W/SKIN, EYES/CLTHG. WEAR PROPER PROT CLTHG TO PVNT EXPOS.
Work Hygienic Practices:REMOVE CONTAMINATED CLOTHING AND WASH BEFORE
REUSING. DO NOT INGEST OR SWALLOW THIS MATERIAL.
Supplemental Safety and Health
MATL TO AVOID: MERCAPTANS. RXN W/CURING AGENTS IS EXOTHERMIC; SMOKE/TOX
FUMES MAY BE EVOLVED IF HEAT OF RXN BECOMES EXCESSIVE DUE TO HIGH
CURING TEMP OR CURING OF LG MASSES OF MATL. EFTS OF OVEREXP: S
TUDIES INDICATE BUTYL & PHENYL GLYCIDYLETHERS MAY INDUCE MUTAGENIC
CHANGES IN LAB ANIMALS. THIS HAS NOT BEEN (ING 5)

Vapor Pres:<1 @ 25C
Vapor Density:HVR/AIR
Spec Gravity:1.60 (H*2O=1)
Solubility in Water:NEGLIGIBLE
Appearance and Odor:BLACK LIQUID.
Percent Volatiles by Volume:<5 WT

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZERS, AMINES, AMIDES, STRONG LEWIS OR MINERAL ACIDS,
THIOSULFATES, CARBOXYLIC ACIDS, ALCOHOL, (SUPDAT)
Stability Condition to Avoid:STORAGE IN OPEN CNTNRS, EXPOS TO HEAT &/OR
OPEN FLAME, UNCONTROLLED MIXING WITH (OR EXPOSURE TO) INCOMPAT
SUBSTANCES.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE.

Waste Disposal Methods:SPILLED MATERIAL AND WATER RINSES ARE CLASSIFIED
AS CHEMICAL WASTE AND MUST BE DISPOSED OF IN ACCORDANCE WITH
CURRENT LOCAL, STATE AND FEDERAL REGULATIONS.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.